InnovaRx Innova Health Strategies

M50.11

Cervical disc disorder with radiculopathy, high cervical region

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 11 never code together
M50.1code
Excludes2
  • brachial radiculitis NOS (M54.13)M54.13
M00-M99chapter
Excludes2
  • arthropathic psoriasis (L40.5-)L40.5-
  • certain conditions originating in the perinatal period (P04-P96)P04-P96
  • certain infectious and parasitic diseases (A00-B99)A00-B99
  • compartment syndrome (traumatic) (T79.A-)T79.A-
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)O00-O9A
  • congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)Q00-Q99
  • endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
  • injury, poisoning and certain other consequences of external causes (S00-T88)S00-T88
  • neoplasms (C00-D49)C00-D49
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)R00-R94

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 7
M50.11code
Inclusion terms
  • C2-C3 disc disorder with radiculopathy
  • C3 radiculopathy due to disc disorder
  • C3-C4 disc disorder with radiculopathy
  • C4 radiculopathy due to disc disorder
M50code
Includes
  • cervicothoracic disc disorders with cervicalgia
  • cervicothoracic disc disorders
M00-M99chapter
Notes
  • Use an external cause code following the code for the musculoskeletal condition, if applicable, to identify the cause of the musculoskeletal condition
Index entries leading here 2
Alongside this code 3 same parent — M50.1
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
M50.1
Block
M40-M54
Siblings
3

Present FY2024–FY2027.